1 locked with NMDA antagonists [AP5 and MK801 (dizocilpine maleate)] indicating glutamate signaling is

2 brain slices to the NMDA receptor antagonist dizocilpine maleate (MK-801) and measuring MK-801-induce

3                The NMDA receptor antagonists dizocilpine maleate (MK-801) and phencyclidine also incr

4 ted exposure to the NMDA receptor antagonist dizocilpine maleate (MK-801) during periadolescence [fro

5  Treatment with the NMDA receptor antagonist dizocilpine maleate (MK-801) for 24 h before birth also

6  inhibition in vivo, because intraperitoneal dizocilpine maleate (MK-801) injection in young adult ra

7  effect of intrathecal NMDA-receptor blocker dizocilpine maleate (MK-801) on the peripheral immune re

8      Four experiments examined the effect of dizocilpine maleate (MK-801), a noncompetitive N-methyl-

9 y-6-nitro-7-sulfamoylbenzo(f)quinoxaline and dizocilpine maleate (MK-801), also suppressed calcium os

10 e present study compared amnestic effects of dizocilpine maleate (MK-801), an NMDA receptor antagonis

11 the noncompetitive NMDA receptor antagonist, dizocilpine maleate (MK-801), on spatial working memory

12 ceptors using the non-competitive antagonist dizocilpine maleate (MK801) arrested the developmental d

13                       Postnatal injection of dizocilpine maleate (MK801), a specific NMDA antagonist,